ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Furmonertinib versus gefitinib in treatment-naive EGFR mutated non-small cell lung cancer: A randomized, double-blind, multi-center, phase III study (FURLONG)

Shi, Y-K.; Chen, G.; Wang, X.; Liu, Y.; Wu, L.; Hao, Y.; Liu, C.; Zhu, S.; Zhang, X.; Li, Y.; Liu, J.; Cao, L.; Cheng, Y.; Zhao, H.; Zhang, S.; Zang, A.; Cui, J.; Feng, J.; Liu, F.; Gu, C.吉林大学; 南通大学; 哈尔滨医科大学; 中国医科大学; 中国医学科学院; 中国医学科学院北京协和医院; 1
2022-4
3被引18阅读
引用收藏
分享
相关
加载中…
  • Patient-reported outcomes of furmonertinib versus gefitinib in patients with locally advanced or metastatic, EGFR mutation-positive non-small cell lung cancer (FURLONG): A multicenter, double-blind, randomized phase 3 study
    Shi, Yuankai; Chen, Gongyan; Wang, Xiang; Liu, Yunpeng; Wu, Lin; Hao, Yanrong; Liu, Chunling; Zhu, Shuyang; Zhang, Xiaodong; Li, Yuping; Liu, Jiwei; Cao, Lejie; Cheng, Ying; Zhao, Hui; Zhang, Shucai; Zang, Ai-min; Cui, Jiuwei; Feng, Jian; Yang, Nong; Hu, JieAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
  • Central nervous system efficacy of furmonertinib versus gefitinib in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: Results from FURLONG study.
    Chen, Gongyan; Wang, Xiang; Liu, Yunpeng; Wu, Lin; Hao, Yanrong; Liu, Chunling; Zhu, Shuyang; Zhang, Xiaodong; Li, Yuping; Liu, Jiwei; Cao, Lejie; Cheng, Ying; Zhao, Hui; Zhang, Shucai; Zang, Aimin; Cui, Jiuwei; Feng, Jian; Liu, Fei; Gu, Chuan; Shi, YuankaiAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.被引 2
  • Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study
    Shi, Yuankai*; Chen, Gongyan; Wang, Xiang; Liu, Yunpeng; Wu, Lin; Hao, Yanrong; Liu, Chunling; Zhu, Shuyang; Zhang, Xiaodong; Li, Yuping; Liu, Jiwei; Cao, Lejie; Cheng, Ying; Zhao, Hui; Zhang, Shucai; Zang, Aimin; Cui, Jiuwei; Feng, Jian; Yang, Nong; Liu, Fei; Jiang, Yong; Gu, ChuanLancet Respiratory Medicine, 2022, 10(11): 1019-1028.被引 45
查看全部 →

会议信息

论文集名
ANNALS OF ONCOLOGY
发表日期
2022-04
起止页码
S27-S27
资助标注
Shanghai Allist Pharmaceutical Technology; China National Major Project for New Drug Innovation [2017ZX09304015]
收录
SCIE

作者

  • S

    Shi, Y-K. (第一作者)

    chinese acad med sci · peking union med coll

  • C

    Chen, G.

    harbin med univ

查看全部 20 位作者收起作者
  • W

    Wang, X.

  • L

    Liu, Y.

  • W

    Wu, L.

    2 · hunan canc hosp

  • H

    Hao, Y.

    peoples hosp guangxi zhuang autonomous reg

  • L

    Liu, C.

    xinjiang med univ

  • Z

    Zhu, S.

    xuzhou med coll

  • Z

    Zhang, X.

    nantong canc hosp

  • L

    Li, Y.

  • L

    Liu, J.

    1 · dalian med univ

  • C

    Cao, L.

    1 · ustc

  • C

    Cheng, Y.

  • Z

    Zhao, H.

    2 · anhui univ

  • Z

    Zhang, S.

    beijing chest hosp · capital med univ

  • Z

    Zang, A.

    hebei univ

  • C

    Cui, J.

    jilin univ

  • F

    Feng, J.

    nantong univ

  • L

    Liu, F.

  • G

    Gu, C.

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417